Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a highly vascularised and poor-prognosis tumour. NGR-hTNF is a vascular-targeting agent consisting of human tumour necrosis factor-alpha fused to the tumour-homing peptide NGR, which is able to selectively bind an aminopeptidase N overexpressed on tumour...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Santoro, A, Pressiani, T, Citterio, G, Rossoni, G, Donadoni, G, Pozzi, F, Rimassa, L, Personeni, N, Bozzarelli, S, Colombi, S, De Braud, F G, Caligaris-Cappio, F, Lambiase, A, Bordignon, C
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2010
Sujets:
Translational Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966632/
https://ncbi.nlm.nih.gov/pubmed/20717115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605858
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires